Science|Business Database: Coronavirus Funding Opportunities

This database is no longer being updated.

As a service to the global R&D community, Science|Business has compiled this database of funding opportunities. Users are encouraged to let us know of funding calls that could be incorporated into the database. Please email all suggestions to [email protected]. The database will be updated daily. For rapid news about COVID-19, see our live blog.

Mitigating the impact of COVID-19 in Bolivia

Date added:

An invitation to contribute to the understanding of the COVID-19 epidemic in Bolivia and its impact on mental health, food security, the economy, and education.

Amount
Decided on a case by case basis
Agency or Funder
Universidad Autónoma Gabriel René Moreno
Eligibility (if available)

Researchers at the Universidad Autónoma Gabriel René Moreno

Foreign participation? (where known)
No

Emergency response to COVID-19 in Peru (CLOSED)

Date added:

Funding for innovative and low-cost solutions focused on COVID-19 diagnosis, treatment, epidemiology, PEE, and telehealth.

Amount
Up to PEN 350,000
Agency or Funder
Fondo Nacional de Desarrollo Científico y Tecnológico, Peru
Eligibility (if available)

Public and private Peruvian institutions, non-profits, universities, and international and foreign centres based in Peru

Foreign participation? (where known)
No

Solutions for product supplies, vaccines, treatment and diagnosis

Date added:

Projects should be able to be quickly implemented and focus on increasing supplies of products to deal with the pandemic, vaccines, improving COVID-19 treatment and diagnosis, and new public health measures.

Amount
€12M
Agency or Funder
Ministry of Science and Innovation
Eligibility (if available)

Companies and technology centres

Maltese COVID-19 research fund

Date added:

Funding for projects started between 1 February 2020 and 31 December 2020 related to the COVID-19 pandemic and potential future disease outbreaks.

Amount
€5.3 M
Agency or Funder
The Malta Council for Science and Technology
Eligibility (if available)

Public, academic and private entities

Foreign participation? (where known)
No

Health research for low- and middle-income countries

Date added:

Projects should focus on epidemiology, clinical management, prevention and social sciences.

Amount
£1M per award
Agency or Funder
UK Department of Health and Social Care and Medical Research Council
Eligibility (if available)

Applications are particularly encouraged from LMIC principal investigators, as well as principal investigators based in the UK working in equitable partnerships with LMIC investigators. Applicants must have a relevant academic affiliation to an eligible institution in an LMIC or the UK.

Foreign participation? (where known)
Yes

Fighting COVID-19 in developing countries

Date added:

Research must address COVID-19 in developing countries in at least one of the following fields: policy and practice to understand and recover from COVID-19; manufacturing and adoption of wide-scale interventions; gathering of data and resources fo

Amount
80% of the full economic cost for UK participants, 100% for LMIC participants
Agency or Funder
The Global Challenges Research Fund and the Newton Fund
Eligibility (if available)

Organisations from the UK and countries on the OECD DAC list of ODA recipients. Principal investigators not from the UK must have held a UKRI grant in the past three years

Foreign participation? (where known)
Yes

Proposals invited for research into the novel coronavirus

Date added:

A call for proposals for better understanding of diagnosis, prevention and management of the virus

Amount
£20 million
Agency or Funder
UK Research and Innovation & National Institute for Health Research (NIHR)
Eligibility (if available)

UK academia, industry experts and international partners

Foreign participation? (where known)
Yes
Date application deadline

Proven vaccine technologies, applicable for large scale manufacturing, for rapid response against novel coronavirus, 2019-nCoV

Date added:

The objective of this Call for Proposals is to rapidly develop and manufacture a proven vaccine approach that can be used against the 2019-nCoV.

Agency or Funder
Norwegian Coalition for Epidemic Preparedness Innovations
Eligibility (if available)

Non-profit research organisations, for-profit companies, international organisations and foundations, joint R&D ventures, government research organisations, and academic institutions. Hold a vaccine technology that has already been proven. Propose only one 2019-nCoV vaccine candidate per application. Have the capacity to start vaccine manufacturing in at short notice. Be an organization that must be willing to transfer their vaccine technology to a global network
of large-scale manufacturers and ideally has its own large-scale manufacturing capabilities

Foreign participation? (where known)
Yes
Date application deadline

Rapid Research Funding Opportunity

Date added:

Accelerate the development, testing and implementation of medical and social countermeasures.

Amount
C$26.75M
Agency or Funder
Canadian Institutes of Health Research
Eligibility (if available)

Principal applicant must be independent researcher, appointed at a CIHR eligible institution; team must include an applicant from OECD-defined Low- or Middle-Income Country

Foreign participation? (where known)
Yes
Date application deadline

Rapid Response Call for "Active intervention development" and "Diagnosing and understanding COVID-19"

Date added:

Research is to focus on vaccines and therapeutics; and on diagnostics, clinical investigations, anthropology investigations, and development of technologies, platforms or systems to accelerate the R&D of diagnostics.

Amount
£20M
Agency or Funder
National Institute for Health Research
Eligibility (if available)

Hosted by a UK institution eligible for UKRI funding. Overseas research organisations in affected countries providing important local engagement can be co-investigators

Foreign participation? (where known)
Yes
Date application deadline

COVID-19 Emergency Call for Proposals: Project Outlines for Call Concerning the Fight Against Coronavirus Disease

Date added:

Our aim is to support research that will enable us to understand and contain the new COVID-19, as well as to improve efficient patient management and public health (national and international) preparedness and response to the current and analogous

Amount
NOK 30M
Agency or Funder
Research Council of Norway
Eligibility (if available)

Approved Norwegian research organisations

Foreign participation? (where known)
No
Date application deadline

2020 COVID-19 and Emerging Infectious Diseases Grant

Date added:

Research relating to COVID-19 that strengthens New Zealand’s research capacity and response to emerging infections disease threats. Must provide evidence within a short- to medium-term timeframe, with project durations up to 24 months.

Amount
$2M (NZ dollars)
Agency or Funder
New Zealand Health Research Council
Eligibility (if available)

Must be based in New Zealand and employed with a New Zealand host organisation. Collaborating researchers from outside New Zealand can, at the HRC’s discretion, be included as named investigators on an HRC contract. See project for details.

Foreign participation? (where known)
No
Date application deadline

Calls for Rapid and Impactful Study Proposals on Behavioural and Psychological Aspects of COVID-19

Date added:

Join a network of labs from 70 countries in the world to help understand the behavioral and psychological aspects of the COVID-19 outbreak. (No funding involved.)

Agency or Funder
Psychological Science Accelerator (PSA)
Foreign participation? (where known)
Yes
Date application deadline

EIC Accelerator Pilot

Date added:

A European Commission call for startups and SMEs with technologies and innovations that could help in treating, testing, monitoring or other aspects of the coronavirus outbreak to apply urgently to the next round of funding from the European Innov

Amount
€164M
Agency or Funder
European Commission
Eligibility (if available)

Annex A

Date application deadline

COVID-19 public health emergency - response, governance and impact

Date added:

Foresighted, basic, retrospective and evidence-based joint research surrounding four aspects in the epidemic prevention and control in terms of responses and management, governance mechanism, economic impact and countermeasures, and social governa

Amount
¥ 500,000 - ¥ 800,000 per project
Agency or Funder
National Science Foundation of China
Eligibility (if available)

2020 NSDC application guidelines

Date application deadline